DEUTSCHE BANK AG\ - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 22 filers reported holding HEMISPHERX BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q2 2016$0
-100.0%
50
-99.9%
0.00%
Q4 2015$6,00075,019
+21334.0%
0.00%
Q2 2015$0
-100.0%
350
-93.0%
0.00%
Q3 2014$1,0005,000
+2400.0%
0.00%
Q4 2013$0
-100.0%
200
-99.9%
0.00%
Q3 2013$76,000324,3190.00%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
Occidental Asset Management, LLC 190,000$390,0000.55%
TWO SIGMA SECURITIES, LLC 21,371$4,0000.01%
VANGUARD GROUP INC 15,403,174$134,405,0000.01%
CITY HOLDING CO 5,000$1,0000.00%
Renaissance Technologies 1,397,800$238,0000.00%
BLACKROCK ADVISORS LLC 68,726$12,0000.00%
WELLS FARGO & COMPANY/MN 10,396$2,0000.00%
NORTHERN TRUST CORP 203,581$35,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 897,977$153,0000.00%
STATE STREET CORP 81,000$14,0000.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders